Global Atherectomy Devices Market Size By Type (Directional Atherectomy Devices, Orbital Atherectomy Devices), By Application (Hospitals, ASCs), By Region, And Segment Forecasts, 2023 to 2032

lobal Atherectomy Devices Market Report Description

The Global Atherectomy Devices Market was valued at USD 1.4 billion in 2023 and is projected to reach USD 2.6 billion by 2031, growing at a CAGR of 8.1% during the forecast period (2023–2031).

Atherectomy devices are minimally invasive surgical instruments used to remove plaque build-up from blood vessels, improving blood flow and reducing the risk of severe cardiovascular complications. The market growth is driven by the rising prevalence of peripheral artery disease (PAD) and coronary artery disease (CAD), an aging global population, and technological advancements in atherectomy systems, including laser, directional, rotational, and orbital atherectomy devices.

Growing patient preference for minimally invasive procedures, coupled with increasing adoption in outpatient surgical centers, is fueling market expansion. Additionally, favorable reimbursement policies and continuous innovation in catheter-based devices are expected to enhance the atherectomy devices market outlook.

Key Market Drivers

Increasing Prevalence of Cardiovascular Disorders

Peripheral artery disease and coronary artery disease are becoming more prevalent due to sedentary lifestyles, diabetes, hypertension, and obesity. This rising patient population significantly increases the demand for atherectomy devices as an alternative to open surgical interventions.

Technological Advancements in Atherectomy Devices

Next-generation devices with improved cutting precision, real-time imaging guidance, and reduced procedural time are driving adoption. Laser-based atherectomy systems and drug-coated atherectomy technologies are gaining popularity for their superior clinical outcomes.

Growing Preference for Minimally Invasive Procedures

Patients and physicians are increasingly opting for minimally invasive treatments that reduce recovery time, hospital stay, and procedural risks. This trend boosts the demand for advanced atherectomy devices.

Market Restraints

High Procedural and Device Costs

The significant upfront cost of atherectomy devices and associated procedural expenses limit adoption, particularly in low- and middle-income countries.

Limited Skilled Professionals

The successful use of advanced atherectomy systems requires specialized training, and a lack of experienced interventional cardiologists in emerging markets hinders market penetration.

Market Opportunities

Expanding Applications in Outpatient and Ambulatory Surgical Centers

The shift toward same-day discharge procedures creates opportunities for atherectomy devices in outpatient settings.

Growing Demand in Emerging Economies

Rapidly improving healthcare infrastructure in Asia-Pacific and Latin America presents untapped growth opportunities for atherectomy device manufacturers.

Integration with Imaging and Robotic-Assisted Systems

Combining atherectomy devices with real-time intravascular imaging and robotic-assisted interventions opens new avenues for precision-based treatments.

Market by System Type Insights

Directional Atherectomy Devices dominated the market in 2023, driven by their effectiveness in treating heavily calcified lesions and reducing restenosis rates.

Laser Atherectomy Devices are expected to witness the fastest growth due to their precision in vaporizing plaque with minimal damage to arterial walls.

Market by End-use Insights

Hospitals held the largest revenue share in 2023, supported by the high volume of cardiovascular interventions and availability of advanced imaging technologies.

Ambulatory Surgical Centers (ASCs) are expected to grow rapidly as cost-effective alternatives for PAD and CAD treatments.

Market by Regional Insights

North America dominated the market in 2023, owing to high cardiovascular disease prevalence, advanced healthcare infrastructure, and strong reimbursement policies.

Asia-Pacific is expected to experience the highest growth during the forecast period due to increasing healthcare investments, rising awareness, and growing patient access to advanced interventional therapies.

Europe holds a significant share with a well-established cardiovascular treatment ecosystem and growing elderly population.

Competitive Scenario

Key players operating in the Global Atherectomy Devices Market include:

Medtronic plc

Boston Scientific Corporation

Cardiovascular Systems, Inc. (CSI)

Philips N.V.

Abbott Laboratories

Straub Medical AG

Bard Peripheral Vascular Inc.

Avinger, Inc.

These companies focus on strategic collaborations, product launches, and technological innovations to strengthen their market presence.

Recent Developments:

2023: Medtronic introduced a next-generation orbital atherectomy device with improved safety features.

2024: Boston Scientific announced a partnership with AI-based imaging companies to enhance precision in atherectomy procedures.

2025: Philips expanded its peripheral intervention portfolio by acquiring a start-up specializing in laser atherectomy systems.

Scope of Work – Global Atherectomy Devices Market

Key Market Developments

2023 – Medtronic launched a cost-effective rotational atherectomy device targeting PAD patients in outpatient settings.

2024 – Boston Scientific gained FDA clearance for a hybrid atherectomy and drug delivery system for PAD treatment.

2025 – Abbott announced a strategic collaboration with AI imaging firms to integrate real-time vessel mapping during atherectomy procedures.

FAQs

What is the current market size of the Global Atherectomy Devices Market?

The market was valued at USD 1.4 billion in 2023.

What is the major growth driver of the Global Atherectomy Devices Market?

The key driver is the rising prevalence of peripheral and coronary artery diseases and the growing demand for minimally invasive vascular interventions.

Which is the largest region during the forecast period in the Global Atherectomy Devices Market?

North America remains the largest region due to high adoption of advanced cardiovascular treatment technologies.

Which segment accounted for the largest market share in the Global Atherectomy Devices Market?

Directional Atherectomy Devices accounted for the largest market share in 2023.

Who are the key market players in the Global Atherectomy Devices Market?

Major players include Medtronic, Boston Scientific, Philips, Abbott, and Cardiovascular Systems, Inc.

Would you like me to also create a visually engaging infographic summarizing the market size, growth rate, and key segments for easy presentation?